News

Tekton

Tekton Research Expands Leadership Team with the Addition of Russell Smith as Chief Operating Officer

COVID-19

Stay Up To Date With COVID-19 Vaccines, Including Boosters

mRNAVaccine

Moderna’s mRNA Cancer Vaccine Shows Promise in Early Trial

Lyme DiseaseVaccine

Who Gets Lyme Disease in Georgia?
(You may be surprised.)

RSVVaccine

Scientists Are Gaining on R.S.V., a Persistent Threat to Children

FlumRNA

mRNA Flu Vaccine Trials Aim for Higher Efficacy Rates

Tekton

Tekton Research Welcomes Back Jason Roth as Chief Business Officer

Vaccine

Covid Success of mRNA Vaccines Opens Way to a New Generation of Drugs

Tekton

Tekton Research Appoints Rene Benedict Business Development Team

Q&ATekton

Insights On Clinical Research with Dr. Robert Lockwood

COVID-19Vaccine

“Moonshot” – An Insider’s Review Of Pfizer’s Ongoing Mission To Save The World

mRNA

mRNA Teaches The Body How To Make Its Own Medicine

Mono/EBV

Epstein-Barr Virus Found to Trigger Multiple Sclerosis

CMV

CMV Through the Eyes of a Mother

Medical Interventions

GSK Kicks off Trials of Pioneering ‘Bioelectronic’ Disease Treatment

Vaccine

Behind Low Vaccination Rates Lurks a More Profound Social Weakness

RSV

Pfizer Announces Start of Phase 3 Clinical Trial in Adults for Its Investigational Vaccine Against Respiratory Syncytial Virus (RSV)

Uncategorized

Fort Collins Patient Testimony Q&A

Uncategorized

RSV Knowledge with Tekton’s Principal Investigator, Clint Flanagan, M.D.

RSV

RSV in Older Adults and Adults with Chronic Medical Conditions